Notable Jumps by % Gain and Mkt Cap Change Ariad Pharmaceuticals (NASDAQ: ARIA) +5.48% heads higher in reaction to ASCO abstracts and continued shift towards positive sentiment based on Iclusig ...
An enormous amount of hype in the last couple of weeks has sent the diabetes and cancer drug developer MannKind Corporation (NASDAQ: MNKD) soaring, particularly after the company’s first quarter ...
Source: George S. Mack of The Life Sciences Report (5/23/13) http://www.thelifesciencesreport.com/pub/na/15301 If investigators could find a way to make breast cancer survivors truly cancer free, and if a diagnosis of ...
I contacted Vivus (NASDAQ: VVUS) directly in an attempt to reach company management to ask them about 10% shareholder First Manhattan and 2% shareholder Alex Denner’s stance against their efforts to ...
BioDelivery Sciences (BDSI) focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible... ...
Amarin Corporation (NASDAQ: AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to slow down its ...
The 6 W’s: Who, what, where, when, why and what of it The RegMed sector is like … a bowl of Jello! Push down on one part and the other ...
Vivus (NASDAQ: VVUS) has been seeing relatively modest growth in QSYMIA (phentermine and topiramate ER) prescriptions since the drug launched in September 2012 under the FDA’s REMS agreement, which restricted ...
Which RegMed companies are making moves in the 1st hour Signs of life … Wright-Medical (WMGI +$0.17) and Reneuron (LON:RENE +$0.16) are the leaders as today’s market opens… …followed by ...
Additional 620,689 shares brings it to $69 M STML’s underwriters have exercised in full their option to purchase an additional ...